HKSE - Delayed Quote HKD
VIVA BIOTECH (1873.HK)
1.720
-0.060
(-3.37%)
As of 11:50:28 AM GMT+8. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
373,990
373,990
383,405
386,051
77,830
Investing Cash Flow
185,899
185,899
439,174
-372,804
-868,835
Financing Cash Flow
-657,764
-657,764
-429,502
-143,196
-653,159
End Cash Position
941,710
941,710
1,036,322
678,569
800,947
Capital Expenditure
-191,671
-191,671
-187,836
-249,542
-566,324
Issuance of Capital Stock
--
--
--
0
18,227
Issuance of Debt
1,119,560
1,119,560
2,045,204
673,041
565,030
Repayment of Debt
-1,735,773
-1,735,773
-2,870,553
-740,911
-975,554
Repurchase of Capital Stock
-23,019
-23,019
-10,274
0
-146,194
Free Cash Flow
182,319
182,319
195,569
136,509
-488,494
12/31/2021 - 5/9/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
2616.HK CStone Pharmaceuticals
3.780
-4.55%
9688.HK Zai Lab Limited
22.900
-4.78%
2256.HK Abbisko Cayman Limited
9.320
-2.72%
6955.HK Shandong Boan Biotechnology Co., Ltd.
11.640
-1.52%
2162.HK Keymed Biosciences Inc.
40.700
-7.71%
6826.HK Shanghai Haohai Biological Technology Co., Ltd.
25.550
-3.22%
6855.HK Ascentage Pharma Group International
47.600
-5.08%
9606.HK Duality Biotherapeutics, Inc.
190.400
-9.76%
2171.HK CARsgen Therapeutics Holdings Limited
20.800
+2.21%
9966.HK Alphamab Oncology
8.580
-3.92%